Form 8-K PFIZER INC For: Jun 18

Go back to Form 8-K PFIZER INC For: Jun 18

Pfizer reaffirms 2026 guidance after CFO transition news

June 18, 2026 1:18 PM EDT

Pfizer (NYSE: PFE) reaffirmed its full-year 2026 financial guidance following the announcement of a Chief Financial Officer transition on June 18, 2026.

The company maintained its forecast for revenues in a range of $59.5 billion to $62.5 billion, and adjusted diluted earnings per share in a range of $2.80 to... More